CMS revised a chapter in the Medicare Program Integrity Manual, which details policies and procedures for Medicare Administrative Contractors and provides guidance for stakeholder engagement. 1. The ...
Coverage determination for oncology drugs can be delayed for months after regulatory approval, a new study suggests. Coverage determination for oncology drugs can be delayed for months after ...
On September 9, 2025, the Government Accountability Office (GAO) published a report titled “National Coverage Determinations Are Generally Timely, but Improvements Are Needed” (the Report). CMS makes ...
On March 16, 2018, the Centers for Medicare and Medicaid Services (CMS) finalized a national coverage determination (NCD) for next-generation sequencing (NGS) tests for cancer, marking a significant ...
The Centers for Medicare & Medicaid Services has proposed three national coverage determinations (NCDs) to establish uniform national policies designed to prevent Medicare from paying for certain ...
In a session held during the Florida Society of Clinical Oncology’s annual meeting in April, panelist James Almas, MD, vice president and national medical director of clinical effectiveness at LabCorp ...
While the Centers for Medicare & Medicaid Services has said it plans to cover what's best known as CAR T-cell therapy for cancer patients, that determination is going to take a little longer than ...
The Centers for Medicare and Medicaid Services said this week it's opening a National Coverage Determination analysis, a process that will allow the agency to review and determine whether Medicare ...
Objectives: To determine (1) whether commercial health plans'coverage criteria for a costly technology-based medical interventionare consistent with recent clinical effectiveness evidence, (2)whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results